Massachusetts General Hospital
Boston, Massachusetts, United States
Purpose
to test the potential use of adjuvant anti-angiogenic and anti-fibrotic treatment to improve drug delivery and increase the efficacy of existing tuberculosis drugs, potentially shortening treatment duration, and thereby improving and simpli
Division
Global Health
Date
November 2015
Region Served
GLOBAL
Committed amount
$1,996,999
Grant topic
Discovery and Translational Sciences, Tuberculosis
Duration (months)
71
Grantee location
Boston, Massachusetts, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.